|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9483
|
|
pubmed:dateCreated |
2005-8-1
|
|
pubmed:abstractText |
Evidence on the effectiveness of highly active antiretroviral therapy (HAART) for HIV-infected individuals is limited. Most clinical trials examined surrogate endpoints over short periods of follow-up and there has been no placebo-controlled randomised trial of HAART. Estimation of treatment effects in observational studies is problematic, because of confounding by indication. We aimed to use novel methodology to overcome this problem in the Swiss HIV Cohort Study.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1474-547X
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
366
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
378-84
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:16054937-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:16054937-Adolescent,
pubmed-meshheading:16054937-Adult,
pubmed-meshheading:16054937-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:16054937-CD4 Lymphocyte Count,
pubmed-meshheading:16054937-Cohort Studies,
pubmed-meshheading:16054937-Disease Progression,
pubmed-meshheading:16054937-Female,
pubmed-meshheading:16054937-HIV Infections,
pubmed-meshheading:16054937-HIV-1,
pubmed-meshheading:16054937-Humans,
pubmed-meshheading:16054937-Male,
pubmed-meshheading:16054937-Middle Aged,
pubmed-meshheading:16054937-Viral Load
|
|
pubmed:articleTitle |
Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study.
|
|
pubmed:affiliation |
Department of Social Medicine, University of Bristol, Canynge Hall, Whiteladies Road, Bristol BS8 2PR, UK.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
